This twittwerX thread from Hannah Barnes is very informative about the ruling from NHS England:
https://twitter.com/hannahsbee/status/1767637851036910024
She explains:
"NSHE consulted on plans to only allow the prescribing of puberty blockers as part of clinicals research or in 'exceptional cases' last summer. Today they've said there will no exceptional cases, as it wouldn't be workable in practice...
Instead, a child's clinician will have to apply under NHSE's 'Individual Funding Request' process. They would have to demonstrate why they believed the case was exceptional and 'why a treatment that is not routinely commissioned by the NHS is an appropriate treatment option.'
There will be no medical pathway when new gender services open on 1st April. Plus, NHSE have said its decision to end prescribing is 'not contingent upon the establishment of a clinical study.' If that study doesn't get ethical approval, PBs will remain unavailable on NHS.
NHSE have made it clear that the decision is based on evidence - like all others areas of medicine. In their opinion, there "is not enough evidence to support the safety or clinical effectiveness of [puberty blockers] to make the treatment routinely available at this time."